← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2009Last known activity
Jan 8, 2022
Timeline
1950s
- Jun 1, 1959
Anhui College of Traditional Chinese Medicine— Founded
Drugs by trial phase (59 distinct, 29 trials)
Phase 4 (20 own, 0 via acquisition)
Phase 3 (13 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (20 own, 0 via acquisition)
Indications
Studied for
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Squamous Cell
- Chronic Kidney Disease-Mineral and Bone Disorder
- Colorectal Neoplasms
- Confusion
- Delirium
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Esophageal Squamous Cell Carcinoma
- Hypertension
- Kidney Diseases
- Lung Diseases, Obstructive
- Neoplasm Metastasis
- Ovarian Hyperstimulation Syndrome
- Pneumonia
- Polyneuropathies
- Pulmonary Disease, Chronic Obstructive
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Recurrence
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Retinal Diseases
- Stomach Neoplasms
- Thrombosis
Recent trials (34)
- NCT05182463Overall official - principal investigatorPhase 4Jan 8, 2022
- NCT05182463OfficialPhase 4Jan 8, 2022
- NCT06195228CollaboratorPhase 4Jan 1, 2020
- NCT03071172CollaboratorPhase 3Mar 1, 2017
- NCT03025399CollaboratorEarly Phase 1Feb 1, 2017
- NCT02971345CollaboratorPhase 3Jan 1, 2017
- NCT03010241CollaboratorEarly Phase 1Jan 1, 2017
- NCT02984865Study directorN/ADec 20, 2016
- NCT03045783CollaboratorN/ADec 1, 2016
- NCT02964195CollaboratorN/ANov 1, 2016
- NCT02673723Reponsible party - principal investigatorPhase 4Mar 1, 2016
- NCT02736552CollaboratorPhase 3Mar 1, 2016
- NCT02646397CollaboratorPhase 4Feb 1, 2016
- NCT02630108CollaboratorPhase 3Dec 1, 2015
- NCT02607072CollaboratorPhase 3Oct 1, 2015
Details
- Founded
- Hefei, CN Jun 1, 1959
- Last known activity
- Jan 8, 2022